Feibi Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Feibi Zheng has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
Yuki Liu
7 shared publications- Elizabeth Wall-Wieler
Global Health Economics and Outcomes Research, Intuitive Surgical, Sunnyvale, California
5 shared publications - Michael Anthony Edwards
Department of Surgery, Mayo Clinic Florida, Jacksonville, Florida
4 shared publications Barbara L. Bass
Houston Methodist Research Institute, Houston, Texas
2 shared publicationsA.F. Shaikh
Department of Surgery, Houston Methodist Hospital, Houston, Texas
1 shared publicationAlex B. Haynes
Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, Texas
1 shared publication
Latest Publications
- 8 December 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 253, 116766
Robotic assisted versus laparoscopic duodenal switch procedures: A nationwide propensity score matched analysis
- 8 December 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 253, 116766
Robotic assisted versus laparoscopic duodenal switch procedures: A nationwide propensity score matched analysis
- Open Access
- 14 July 2025
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 14 (8) , e250013
A protocol for three observational cohort studies evaluating adverse outcomes, excess costs and repeat procedures after surgery for breast cancer in the USA
Aim: Surgical therapy for early-stage breast cancer, including lumpectomy and mastectomy, are common treatments for early-stage breast cancer. Despite having favorable survival outcomes, these procedures can lead to repeat surgeries, adverse outcomes, excess costs and potentially aggressive resections. This is a protocol for a study aims to evaluate three main areas: the risk factors, costs and complications of re-operations following lumpectomy (‘Lumpectomy Cohort’), the identification of patients potentially overtreated with mastectomy (‘Mastectomy Cohort’) and the cost and healthcare resource utilization associated with nipple necrosis following nipple-sparing mastectomy (NSM) (‘Nipple Necrosis Cohort’). Materials & methods: A retrospective cohort analysis will be conducted using Optum’s de-identified Market Clarity Data (2007–2023), which integrates medical and pharmacy claims with electronic health records. Patients will be included based on specific procedure and diagnosis codes, with additional data extracted from unstructured clinical notes using natural language processing. The study will analyze patient demographics, baseline health, surgical details, and outcomes, including costs, complications, reoperations and mortality. Data will be analyzed descriptively, with Kaplan–Meier analyses for time-to-event outcomes and Wilcoxon Signed Rank tests for cost comparisons. Results: Preliminary cohorts are expected to include 26,472 lumpectomy patients, 16,836 mastectomy patients and 6828 NSM patients with 541 cases of nipple necrosis. Conclusion: This study will provide comprehensive insights into the patient journey – highlighting the costs and patient outcomes following lumpectomy, mastectomy and NSM – potentially guiding better clinical decision-making and resource allocation.
- 14 July 2025
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 14 (8) , e250013
Open AccessA protocol for three observational cohort studies evaluating adverse outcomes, excess costs and repeat procedures after surgery for breast cancer in the USA
Aim: Surgical therapy for early-stage breast cancer, including lumpectomy and mastectomy, are common treatments for early-stage breast cancer. Despite having favorable survival outcomes, these procedures can lead to repeat surgeries, adverse outcomes, excess costs and potentially aggressive resections. This is a protocol for a study aims to evaluate three main areas: the risk factors, costs and complications of re-operations following lumpectomy (‘Lumpectomy Cohort’), the identification of patients potentially overtreated with mastectomy (‘Mastectomy Cohort’) and the cost and healthcare resource utilization associated with nipple necrosis following nipple-sparing mastectomy (NSM) (‘Nipple Necrosis Cohort’). Materials & methods: A retrospective cohort analysis will be conducted using Optum’s de-identified Market Clarity Data (2007–2023), which integrates medical and pharmacy claims with electronic health records. Patients will be included based on specific procedure and diagnosis codes, with additional data extracted from unstructured clinical notes using natural language processing. The study will analyze patient demographics, baseline health, surgical details, and outcomes, including costs, complications, reoperations and mortality. Data will be analyzed descriptively, with Kaplan–Meier analyses for time-to-event outcomes and Wilcoxon Signed Rank tests for cost comparisons. Results: Preliminary cohorts are expected to include 26,472 lumpectomy patients, 16,836 mastectomy patients and 6828 NSM patients with 541 cases of nipple necrosis. Conclusion: This study will provide comprehensive insights into the patient journey – highlighting the costs and patient outcomes following lumpectomy, mastectomy and NSM – potentially guiding better clinical decision-making and resource allocation.
- Open Access
- 15 February 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , 742-751
Longitudinal changes in positive airway pressure device use after metabolic surgery: a 3-year matched cohort study of National Claims Data
- 15 February 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (7) , 742-751
Open AccessLongitudinal changes in positive airway pressure device use after metabolic surgery: a 3-year matched cohort study of National Claims Data
- Open Access
- 15 September 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (2) , 152-157
Statin use trajectories postbariatric surgery: a matched cohort analysis
- 15 September 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (2) , 152-157
Open AccessStatin use trajectories postbariatric surgery: a matched cohort analysis
- 13 June 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 237, 115801
Thirty day outcomes for laparoscopic versus robotic sleeve gastrectomy: Does the stapler matter?
- 13 June 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 237, 115801
Thirty day outcomes for laparoscopic versus robotic sleeve gastrectomy: Does the stapler matter?
- Open Access
- 5 June 2024
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 67 (4) , 581-585
New-Onset Type 2 Diabetes after Bariatric Surgery: A Matched Cohort Study
- 5 June 2024
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 67 (4) , 581-585
Open AccessNew-Onset Type 2 Diabetes after Bariatric Surgery: A Matched Cohort Study